J. Lobell
Director/Board Member at FORTRESS BIOTECH, INC.
Net worth: 198 990 $ as of 2024-04-29
Network origin in J. Lobell first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
Covington & Burling LLP
 Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Covington & Burling LLP provides legal services. It also provides support services in the following administrative departments including accounting, human resources, information research services, information technology services, library, operations, marketing, practice systems support, recruitment, attorney and alumni relations, and professional development. The company was founded by J. Harry Covington and Edward B. Burling on January 1, 1919 and is headquartered in Washington, DC.
27
| Private Company | Miscellaneous Commercial Services | 27 |
Meridian Capital Group LLC
 Meridian Capital Group LLC Finance/Rental/LeasingFinance Meridian Capital Group LLC provides mortgage brokerage services. Its services include financing solutions for property such as student housing, self storage and land, fixed rate loans, construction and forward commitment, multifamily, office and retail. The company was founded by Ralph Herzka, Mark Mansfield and Howard J Zuckerman in 1991 and is headquartered in New York, NY.
24
| Holding Company | Finance/Rental/Leasing | 24 |
Yale Law School
19
| College/University | Other Consumer Services | 19 |
| Subsidiary | Pharmaceuticals: Major | 16 | |
GMF Capital LLC
 GMF Capital LLC Investment ManagersFinance GMF Capital LLC (GMF Capital) is a private equity firm founded in 2013 by J Jay Lobell and Gary M. Fegel. The firm is headquartered in New York.
15
| Private Company | Investment Managers | 15 |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
11
| Private Company | Investment Managers | 11 |
CRC Parent Corp.
 CRC Parent Corp. Pharmaceuticals: MajorHealth Technology CRC Parent Corp. provides institutional pharmacy services in New York. Its client base includes skilled nursing facilities and other long-term care facilities. The firm provides prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies to more than 65000 institutional residents. The company was founded in 1958 and is headquartered in Long Beach, NY.
9
| Extinct | Pharmaceuticals: Major | 9 |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America.
7
| Extinct | Pharmaceuticals: Major | 7 |
SavaSeniorCare LLC
 SavaSeniorCare LLC Hospital/Nursing ManagementHealth Services SavaSeniorCare LLC provides health care services for elder people. Its services include physical therapy, occupational therapy, speech therapy, wound care, rehabilitation services, intravenous therapy, respiratory therapy, dementia, and bariatric services. The company was founded in 2004 and is headquartered in Atlanta, GA.
7
| Private Company | Hospital/Nursing Management | 7 |
Tikvah Therapeutics, Inc.
 Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Tikvah Therapeutics, Inc. acquires, develops and commercializes therapeutics addressing medical needs relating to the central nervous system. Its products include TIK-101 (dCS) and TIK-201(NaPB). The company was founded in April 2006 and is located in Atlanta, GA.
5
| Private Company | Medical Specialties | 5 |
Jsb Capital Group LLC
 Jsb Capital Group LLC Real Estate DevelopmentFinance JSB Capital Group LLC is a privately-held real estate investment management firm that invests in various asset classes, including multifamily assets and vacation rental properties. The private company is based in Burlingame and was founded by J. Jay Lobell, who has been the CEO since incorporation. The company has invested over $3 billion of equity, representing over $10 billion of asset value. JSB Capital Group actively sources opportunistic investments across the asset spectrum and devises creative capital markets and operational strategies to drive superior risk-adjusted cash yields and long-term returns.
3
| Private Company | Real Estate Development | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to J. Lobell via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer Chairman Director/Board Member | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Union College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Florida | College/University | Graduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
| WOODBROOK GROUP HOLDINGS INC. | Investment Managers | Chairman Director of Finance/CFO | |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investment Managers | Chief Executive Officer General Counsel Private Equity Investor | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Graduate Degree | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Founder General Counsel | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Chief Operating Officer | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Secretary | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Corporate Secretary Director of Finance/CFO | |
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Secretary Director of Finance/CFO | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| TFF PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO | |
Flame Biosciences LLC
 Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 50 |
| Italy | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 17 |
| Finance | 9 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 328 |
| Corporate Officer/Principal | 175 |
| Chairman | 83 |
| Independent Dir/Board Member | 81 |
| Undergraduate Degree | 74 |
Most connected contacts
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Amy Schulman | 45 |
| Thomas Wiggans | 31 |
| Bobby Sandage | 29 |
| Malcolm Hoenlein | 28 |
| Michael Weiss | 25 |
| Lindsay Rosenwald | 23 |
| Stuart Eizenstat | 21 |
| Stephen Rocamboli | 20 |
| Harlan Weisman | 20 |
| Joe Tsai | 19 |
| David R. Fontaine | 18 |
| Jonathan Biller | 17 |
| Michael Rogers | 16 |
| Mark Auerbach | 15 |
- Stock Market
- Insiders
- J. Lobell
- Company connections
